Growth Metrics

Moderna (MRNA) Acquisitions (2023)

Moderna (MRNA) has disclosed Acquisitions for 1 consecutive years, with $85.0 million as the latest value for Q1 2023.

  • On a quarterly basis, Acquisitions changed N/A to $85.0 million in Q1 2023 year-over-year; TTM through Dec 2023 was $85.0 million, a N/A change, with the full-year FY2023 number at $85.0 million, changed N/A from a year prior.
  • Acquisitions was $85.0 million for Q1 2023 at Moderna.
  • In the past five years, Acquisitions ranged from a high of $85.0 million in Q1 2023 to a low of $85.0 million in Q1 2023.